Impact of delisting ARBs, apart from losartan, on ARB utilisation patterns in Denmark: Implications for other countries

Ulrik Hesse, Brian Godman*, Max Petzold, Andrew Martin, Rickard E. Malmström

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Impact of delisting ARBs, apart from losartan, on ARB utilisation patterns in Denmark: Implications for other countries'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences

Social Sciences